These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31669214)

  • 1. Aspirin-loaded nanoexosomes as cancer therapeutics.
    Tran PHL; Wang T; Yin W; Tran TTD; Nguyen TNG; Lee BJ; Duan W
    Int J Pharm; 2019 Dec; 572():118786. PubMed ID: 31669214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a nanoamorphous exosomal delivery system as an effective biological platform for improved encapsulation of hydrophobic drugs.
    Tran PHL; Wang T; Yin W; Tran TTD; Barua HT; Zhang Y; Midge SB; Nguyen TNG; Lee BJ; Duan W
    Int J Pharm; 2019 Jul; 566():697-707. PubMed ID: 31207280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
    Hu YB; Yan C; Mu L; Mi YL; Zhao H; Hu H; Li XL; Tao DD; Wu YQ; Gong JP; Qin JC
    Oncogene; 2019 Mar; 38(11):1951-1965. PubMed ID: 30390075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
    Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer.
    Li Y; Gao Y; Gong C; Wang Z; Xia Q; Gu F; Hu C; Zhang L; Guo H; Gao S
    Nanomedicine; 2018 Oct; 14(7):1973-1985. PubMed ID: 29935333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin suppresses the maintenance of colorectal cancer stem-like cells by inhibiting PP2A/AKT/mTOR pathways.
    Wang JY; Chang CC; Chiang CC; Chen WM; Hung SC
    J Cell Biochem; 2012 May; 113(5):1733-43. PubMed ID: 22213051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle.
    Zhang C; Han M; Zhang F; Yang X; Du J; Zhang H; Li W; Chen S
    Int J Nanomedicine; 2020; 15():885-900. PubMed ID: 32103944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles.
    Ning ST; Lee SY; Wei MF; Peng CL; Lin SY; Tsai MH; Lee PC; Shih YH; Lin CY; Luo TY; Shieh MJ
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):17793-804. PubMed ID: 27348241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.
    Cheng WC; Liao TT; Lin CC; Yuan LE; Lan HY; Lin HH; Teng HW; Chang HC; Lin CH; Yang CY; Huang SC; Jiang JK; Yang SH; Yang MH; Hwang WL
    Int J Cancer; 2019 Oct; 145(8):2209-2224. PubMed ID: 30980673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
    Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
    Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function.
    Chen J; Xu R; Xia J; Huang J; Su B; Wang S
    Pathol Res Pract; 2019 Jun; 215(6):152379. PubMed ID: 30878308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.
    Li Y; Duo Y; Bao S; He L; Ling K; Luo J; Zhang Y; Huang H; Zhang H; Yu X
    Int J Nanomedicine; 2017; 12():6239-6257. PubMed ID: 28894364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.
    Yu B; Wang Y; Yu X; Zhang H; Zhu J; Wang C; Chen F; Liu C; Wang J; Zhu H
    Int J Nanomedicine; 2017; 12():2553-2567. PubMed ID: 28435246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.
    Gernapudi R; Yao Y; Zhang Y; Wolfson B; Roy S; Duru N; Eades G; Yang P; Zhou Q
    Breast Cancer Res Treat; 2015 Apr; 150(3):685-95. PubMed ID: 25783182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells.
    Orienti I; Salvati V; Sette G; Zucchetti M; Bongiorno-Borbone L; Peschiaroli A; Zolla L; Francescangeli F; Ferrari M; Matteo C; Bello E; Di Virgilio A; Falchi M; De Angelis ML; Baiocchi M; Melino G; De Maria R; Zeuner A; Eramo A
    J Exp Clin Cancer Res; 2019 Aug; 38(1):373. PubMed ID: 31439019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect.
    Zhang X; Zhang T; Ye Y; Chen H; Sun H; Zhou X; Ma Z; Wu B
    Eur J Pharm Biopharm; 2015 Aug; 94():30-41. PubMed ID: 25936860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Acetylantroquinonol B inhibits colorectal cancer tumorigenesis and suppresses cancer stem-like phenotype.
    Chang TC; Yeh CT; Adebayo BO; Lin YC; Deng L; Rao YK; Huang CC; Lee WH; Wu AT; Hsiao M; Wu CH; Wang LS; Tzeng YM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):258-68. PubMed ID: 26235807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.